Funding news
Life Biosciences logo

Life Biosciences Raises $120.0M Series D Funding

Recently funded · $120.0M Series dHospitals and Health CareUSView source

Get the full Life Biosciences company profile

Access contacts, investors, buying signals & more

Open in Dashboard

The quest to reverse age-related diseases just got a significant financial boost, with Life Biosciences announcing a $120.0M Series d funding round. The biotech company, which specializes in epigenetic restoration, is the sole holder of intellectual property for its technology and has already secured FDA approval to advance it into human clinical studies.

Life Biosciences' platform has shown promise in preclinical models, demonstrating the potential to rejuvenate cells and restore function across various age-related conditions. While its initial clinical trial targets optic neuropathies, the company's science aims to bring broader therapeutic benefits to patients.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series d rounds

Companies that recently closed a Series d round.

#CompanyAmount
1
Ethic logo

Ethic

United States

$150.0M
2
Cagent Vascular logo

Cagent Vascular

United States

$41.0M
3
HIF Global logo

HIF Global

$164.0M
4
Rivermark Medical, Inc. logo

Rivermark Medical, Inc.

United States

$20.0M
5
Sindhuja Microcredit Pvt. Ltd. logo

Sindhuja Microcredit Pvt. Ltd.

India

$5.0M